Daniel Razzano, MD
Internal Medicine · Clermont
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 10 years
- Graduated 2016
Offices
1 location · Orlando Physicians Network Inc · 231 clinicians in this group
Hospitals listed: Orlando Health Orlando Regional Medical Center · Orlando Health South Lake Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Razzano’s office at (407) 905-6006 to ask if they take your plan before you enroll.
California Medical Board record
Licence A172893 · Delinquent
Licence status: Delinquent · since 2021 · expires 2025-05-31 · St. George'S University School of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Florida ME166822Medical Doctor · since 2024 · expires 2028-01-31Matched by name, not licence number; check the name before relying on it.ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
1 placement
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
- Internal Medicine
Education
- St. George'S University2011–2016
Residency and fellowship
- Danbury Hospital, INTERNAL MEDICINEDanbury, CT · 2016–2019
What else the board holds
Hospitals they may admit to
Where the clinician told their state board they may admit and treat patients.
- Veterans Affairs Medical Center
Also licensed in
States the clinician told their board they are also licensed in. Only the states we check are verified.
California
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Orlando HealthOrlando, FLAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Orlando Health, which runs 5 hospitalsPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 15.9 (13.7 to 18.4) · 862 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.335, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.377, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.209, Oct 2024 – Sep 2025Better than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 3.9 (3 to 5.1) · 862 cases, Jan 2024 – Dec 2024
- Orlando Health South Lake HospitalClermont, FLAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Orlando Health, which runs 5 hospitalsPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.217, Oct 2024 – Sep 2025
See every measure and the patient survey for Orlando Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 4 better, 4 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 15.9 (13.7 to 18.4) · 862 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.335 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.377 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.209 | Better | Oct 2024 – Sep 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 3.9 (3 to 5.1) · 862 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.38 (0.66 to 2.11) · 4,146 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.81 to 1.17) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 146.42 (113.4 to 179.44) · 286 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.2 · 234 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 280 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.4 · 379 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.5 · 990 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.1 · 735 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.8 · 995 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 14,199 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0.03 to 0.31) · 23,330 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.19 (0.04 to 0.34) · 23,568 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.45 (3.21 to 5.7) · 7,572 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.98 (0 to 2.14) · 4,099 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.41 (1.42 to 3.41) · 7,259 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.47 (3.97 to 10.97) · 3,998 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.18 (5.02 to 9.35) · 4,045 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.76 (0.46 to 3.05) · 1,032 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.16 to 0.88) · 17,034 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3 · 1,887 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 1.241 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.6 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.045 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 1,030 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23.2 · 2,627 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 436 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.5 · 1,221 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -20.1 · 837 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.3 · 1,563 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 1,927 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.1 · 336 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.7 · 741 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.4 to 15.9) · 858 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 1,366 cases | No different | Jan 2024 – Dec 2024 |
What patients said (10,480 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 63% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Orlando Health South Lake Hospital
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 5 the same, 1 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.217 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.87 (0 to 1.86) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.7 (0.35 to 1.05) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 134.54 (80.76 to 188.31) · 39 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.8 · 163 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 233 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.9 · 458 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.7 · 389 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 283 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 4,898 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.14 (0 to 0.34) · 8,128 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.48) · 8,123 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.9 (0.79 to 5.01) · 1,364 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.22 to 3.38) · 434 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.03 (0.51 to 3.54) · 1,318 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.1 (0 to 14.31) · 463 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.27 (0.35 to 8.2) · 435 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.18 to 3.17) · 257 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.86) · 5,198 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 217 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.562 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.357 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.851 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.7 · 373 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.5 · 965 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -21 · 227 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -24.8 · 542 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 2 · 423 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.5 · 718 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 7.6 · 203 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.8 · 283 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (10.4 to 18.1) · 433 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.2) · 477 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,330 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Medicaid work
$13,521 in 2021
Medicaid paid $13,521 for 273 billed services this clinician did in 2021, up to 35 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 205 | $11,334 |
| Short return visit (20+ min) | 68 | $2,187 |
| 2021 | 273 | 2 | 35 | $13,521 |
| 2020 | 191 | 5 | 23 | $8,258 |
| 2019 | 152 | 6 | 21 | $3,777 |
See the largest Medicaid services in earlier years
2020
| Return visit (30+ min) | 105 | $6,190 |
| Short return visit (20+ min) | 40 | $1,779 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 13 | $247 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 15 | $42 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 18 | $0 |
2019
| Return visit (30+ min) | 36 | $2,095 |
| Short return visit (20+ min) | 27 | $1,130 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 21 | $304 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 13 | $199 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 17 | $49 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 38 | $0 |
Drugs they prescribed that Part D paid
$4,023
Pharmacies billed $4,023 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 31) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
23 generic and fewer than 11 brand-name prescriptions · $4,023 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 31 | None | 0% (0) | None | $4,023 |
| 2022 | 57 | 32 | 0% (0) | None | $2,781 |
| 2021 | 1,176 | 168 | None | 15% | $95,057 |
| 2020 | 1,176 | 191 | 1% (11) | 18% | $91,494 |
| 2019 | 256 | 125 | None | None | $15,855 |
| 2018 | 269 | 81 | None | None | $32,771 |
| 2017 | 136 | 56 | None | None | $7,326 |
| 2016 | 30 | 16 | None | 40% | $4,757 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2021: 31 drugs
| Eliquis | 13 | $7,791 | $599 |
| Lantus Solostar | 11 | $5,227 | $475 |
| Azelastine | 25 | $1,414 | $57 |
| Atorvastatin | 108 | $1,169 | $11 |
| Levothyroxine | 46 | $1,036 | $23 |
| Albuterol Sulfate Hfa | 21 | $942 | $45 |
| Gabapentin | 27 | $684 | $25 |
| Potassium Chloride | 14 | $670 | $48 |
| Amlodipine Besylate | 68 | $597 | $9 |
| Pravastatin | 23 | $483 | $21 |
| Fluticasone Propionate | 29 | $480 | $17 |
| Famotidine | 13 | $441 | $34 |
| Metoprolol | 16 | $427 | $27 |
| Losartan | 37 | $406 | $11 |
| Quetiapine | 15 | $377 | $25 |
| Rosuvastatin | 13 | $332 | $26 |
| Losartan-Hydrochlorothiazide | 13 | $318 | $24 |
| Hydrochlorothiazide | 31 | $291 | $9 |
| Omeprazole | 11 | $250 | $23 |
| Montelukast | 16 | $224 | $14 |
| Trazodone | 22 | $221 | $10 |
| Pantoprazole | 13 | $221 | $17 |
| Lisinopril | 24 | $165 | $7 |
| Metoprolol | 11 | $155 | $14 |
| Metformin | 31 | $153 | $5 |
| Furosemide | 16 | $137 | $9 |
| Simvastatin | 14 | $136 | $10 |
| Clonazepam | 13 | $123 | $9 |
| Ibuprofen | 12 | $119 | $10 |
| Metformin Hcl Er | 18 | $116 | $6 |
| Atenolol | 15 | $78 | $5 |
2020: 30 drugs
| Linzess | 12 | $5,537 | $461 |
| Humalog Mix 75-25 | 12 | $5,047 | $421 |
| Breo Ellipta | 12 | $4,596 | $383 |
| Levemir Flextouch | 13 | $3,884 | $299 |
| Diovan | 11 | $2,191 | $199 |
| Levothyroxine | 58 | $1,543 | $27 |
| Azelastine | 25 | $1,305 | $52 |
| Atorvastatin | 87 | $1,158 | $13 |
| Fluticasone Propionate | 36 | $799 | $22 |
| Rosuvastatin | 15 | $625 | $42 |
| Albuterol Sulfate Hfa | 18 | $620 | $34 |
| Amlodipine Besylate | 61 | $572 | $9 |
| Gabapentin | 32 | $454 | $14 |
| Metoprolol | 14 | $446 | $32 |
| Bupropion Xl | 11 | $399 | $36 |
| Losartan | 26 | $359 | $14 |
| Famotidine | 16 | $358 | $22 |
| Pravastatin | 19 | $331 | $17 |
| Hydrochlorothiazide | 37 | $319 | $9 |
| Pantoprazole | 14 | $283 | $20 |
| Lisinopril | 34 | $239 | $7 |
| Metoprolol | 14 | $228 | $16 |
| Trazodone | 15 | $170 | $11 |
| Furosemide | 15 | $167 | $11 |
| Metformin | 33 | $137 | $4 |
| Clonazepam | 22 | $136 | $6 |
| Amlodipine Besylate-Benazepril | 12 | $109 | $9 |
| Lorazepam | 11 | $73 | $7 |
| Prednisone | 11 | $70 | $6 |
| Metformin Hcl Er | 11 | $63 | $6 |
2019: 3 drugs
| Atorvastatin | 15 | $318 | $21 |
| Amlodipine Besylate | 13 | $125 | $10 |
| Lisinopril | 12 | $84 | $7 |
2018: 3 drugs
| Atorvastatin | 19 | $396 | $21 |
| Metformin | 12 | $123 | $10 |
| Amlodipine Besylate | 12 | $64 | $5 |
Money from drug and device companies
$426 in 2025
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Airsupra | $75 | 4 payments
|
| Novo Nordisk | Ozempic | $74 | 3 payments
|
| Amgen | Otezla | $56 | 3 payments
|
| Abbvie | Ubrelvy | $45 | 2 payments
|
| Exact Sciences | Cologuard Collection Kit | $33 | 2 payments
|
| GlaxoSmithKline | Shingrix | $27 | 1 payment
|
See all 21 published payments
| Amgen | Meals · 2025-12-15 | Repatha | $21 |
| Exact Sciences | Meals · 2025-12-08 | Cologuard Collection Kit | $18 |
| Abbvie | Meals · 2025-12-01 | Ubrelvy | $24 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-13 | Airsupra | $17 |
| Amgen | Meals · 2025-11-06 | Otezla | $20 |
| Lundbeck | Meals · 2025-10-28 | Rexulti | $23 |
| Pfizer | Meals · 2025-10-27 | Nurtec Odt | $22 |
| Novo Nordisk | Meals · 2025-10-05 | Ozempic | $24 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-24 | Breztri | $20 |
| GlaxoSmithKline | Meals · 2025-09-09 | Shingrix | $27 |
| Novo Nordisk | Meals · 2025-09-03 | Ozempic | $24 |
| Amgen | Meals · 2025-08-06 | Otezla | $15 |
| Exact Sciences | Meals · 2025-08-05 | Cologuard Collection Kit | $15 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-31 | Farxiga | $19 |
| Abbvie | Meals · 2025-07-29 | Ubrelvy | $21 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-14 | Airsupra | $19 |
| Lilly USA | Meals · 2025-07-08 | Mounjaro | $16 |
| Dynavax Technologies | Meals · 2025-06-30 | Heplisav-B | $23 |
| Novo Nordisk | Meals · 2025-06-25 | None | $26 |
| Shield Therapeutics | Meals · 2025-06-12 | Accrufer | $17 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-06-04 | Jardiance | $15 |
Professional record
- NPI
- 1003278573
- Licence
- CA A172893California A172893: Delinquent · expires 2025-05-31Florida ME166822: Active
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 17325 Pagonia Rd, Clermont, FL, 34711
- NPI first listed
- 2016-03-24
- NPI last updated
- 2025-06-02
- NPI record certified
- 2025-06-02
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3801 Miranda Ave, Palo Alto, CA, 94304